Comprehensive Laboratory Data Analysis to Predict the Clinical Severity of Coronavirus Disease 2019 in 1,952 Patients in Daegu, Korea
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Laboratory parameter abnormalities are commonly observed in COVID-19 patients; however, their clinical significance remains controversial. We assessed the prevalence, characteristics, and clinical impact of laboratory parameters in COVID-19 patients hospitalized in Daegu, Korea. Methods: We investigated the clinical and laboratory parameters of 1,952 COVID-19 patients on admission in nine hospitals in Daegu, Korea. The average patient age was 58.1 years, and 700 (35.9%) patients were men. The patients were classified into mild (N=1,612), moderate (N=294), and severe (N=46) disease groups based on clinical severity scores. We used chi-square test, multiple comparison analysis, and multinomial logistic regression to evaluate the correlation between laboratory parameters and disease severity. Results: Laboratory parameters on admission in the three disease groups were significantly different in terms of hematologic (Hb, Hct, white blood cell count, lymphocyte%, and platelet count), coagulation (prothrombin time and activated partial thromboplastin time), biochemical (albumin, aspartate aminotransferase, alanine aminotransferase, lactate, blood urea nitrogen, creatinine, and electrolytes), inflammatory (C-reactive protein and procalcitonin), cardiac (creatinine kinase MB isoenzyme and troponin I), and molecular virologic (Ct value of SARS-CoV-2 RdRP gene) parameters. Relative lymphopenia, prothrombin time prolongation, and hypoalbuminemia were significant indicators of COVID-19 severity. Patients with both hypoalbuminemia and lymphopenia had a higher risk of severe COVID-19. Conclusions: Laboratory parameter abnormalities on admission are common, are significantly associated with clinical severity, and can serve as independent predictors of COVID-19 severity. Monitoring the laboratory parameters, including albumin and lymphocyte count, is crucial for timely treatment of COVID-19.
Abstract
Background: Laboratory parameter abnormalities are commonly observed in COVID-19 patients; however, their clinical significance remains controversial. We assessed the prevalence, characteristics, and clinical impact of laboratory parameters in COVID-19 patients hospitalized in Daegu, Korea. Methods: We investigated the clinical and laboratory parameters of 1,952 COVID-19 patients on admission in nine hospitals in Daegu, Korea. The average patient age was 58.1 years, and 700 (35.9%) patients were men. The patients were classified into mild (N=1,612), moderate (N=294), and severe (N=46) disease groups based on clinical severity scores. We used chi-square test, multiple comparison analysis, and multinomial logistic regression to evaluate the correlation between laboratory parameters and disease severity. Results: Laboratory parameters on admission in the three disease groups were significantly different in terms of hematologic (Hb, Hct, white blood cell count, lymphocyte%, and platelet count), coagulation (prothrombin time and activated partial thromboplastin time), biochemical (albumin, aspartate aminotransferase, alanine aminotransferase, lactate, blood urea nitrogen, creatinine, and electrolytes), inflammatory (C-reactive protein and procalcitonin), cardiac (creatinine kinase MB isoenzyme and troponin I), and molecular virologic (Ct value of SARS-CoV-2 RdRP gene) parameters. Relative lymphopenia, prothrombin time prolongation, and hypoalbuminemia were significant indicators of COVID-19 severity. Patients with both hypoalbuminemia and lymphopenia had a higher risk of severe COVID-19. Conclusions: Laboratory parameter abnormalities on admission are common, are significantly associated with clinical severity, and can serve as independent predictors of COVID-19 severity. Monitoring the laboratory parameters, including albumin and lymphocyte count, is crucial for timely treatment of COVID-19.
참고문헌 (38)
- Xu Z, "Pathological findings of COVID-19 associated with acute respiratory distress syndrome", Lancet Respir Med, 8, pp.420~422 (2020)
- Kim Il-Hwan, "Early Laboratory Preparedness of the Korea Disease Control and Prevention Agency and Response to Unknown Pneumonia Outbreak from Wuhan, China, in January 2020", Annals of Laboratory Medicine, 41(6), pp.532~539 (2021), 대한진단검사의학회[DOI]
- Argenziano MG, "Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York : retrospective case series", BMJ, 369, pp.m1996~ (2020)
- Chen N, "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study", Lancet, 395, pp.507~513 (2020)
- Sung Ho Kyung, "Clinical Course and Outcomes of 3,060 Patients with Coronavirus Disease 2019 in Korea, January–May 2020", Journal of Korean Medical Science, 35(30), pp.1~11 (2020), 대한의학회[DOI]
- "Patient Treatment and Management" (2020)[URL]
- Kim JH, "How South Korea responded to the Covid-19 outbreak in Daegu", NEJM Catal Innov Care Deliv, 1 (2020)[DOI]
- Skevaki C, "Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus", J Infect, 81, pp.205~212 (2020)
- Henry BM, "Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis", Clin Chem Lab Med, 58, pp.1021~1028 (2020)
- Fan BE, "Hematologic parameters in patients with COVID-19 infection", Am J Hematol, 95, pp.E131~E134 (2020)
- WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection, "A minimal common outcome measure set for COVID-19 clinical research", Lancet Infect Dis, 20, pp.e192~7 (2020)
- Scheffé H, "A method for judging all contrasts in the analysis of variance", Biometrika, 40, pp.87~104 (1953)
- Yang J, "Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2 : a systematic review and meta-analysis", Int J Infect Dis, 94, pp.91~95 (2020)
- Opal SM, "The immunopathogenesis of sepsis in elderly patients", Clin Infect Dis, 41(S7), pp.S504~S512 (2005)
- Takahashi T, "Sex differences in immune responses that underlie COVID-19 disease outcomes", Nature, 588, pp.315~320 (2020)
- Zhu B, "Correlation between white blood cell count at admission and mortality in COVID-19 patients : a retrospective study", BMC Infect Dis, 21, pp.574~ (2021)
- Henry BM, "COVID-19, ECMO, and lymphopenia : a word of caution", Lancet Respir Med, 8, pp.e24~ (2020)
- Zhao Q, "Lymphopenia is associated with severe coronavirus disease 2019(COVID-19)infections : A systemic review and meta-analysis", Int J Infect Dis, 96, pp.131~135 (2020)
- Tan L, "Lymphopenia predicts disease severity of COVID-19 : a descriptive and predictive study", Signal Transduct Target Ther, 5, pp.33~ (2020)
- Zheng HY, "Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients", Cell Mol Immunol, 17, pp.541~543 (2020)
- Zheng M, "Functional exhaustion of antiviral lymphocytes in COVID-19 patients", Cell Mol Immunol, 17, pp.533~535 (2020)
- Fischer K, "Inhibitory effect of tumor cell-derived lactic acid on human T cells", Blood, 109, pp.3812~3819 (2007)
- Liao D, "Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19 : a retrospective cohort study", Lancet Haematol, 7, pp.e671~e678 (2020)
- Tang N, "Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia", J Thromb Haemost, 18, pp.844~847 (2020)
- Xiong M, "Changes in blood coagulation in patients with severe coronavirus disease 2019(COVID-19) : a meta-analysis", Br J Haematol, 189, pp.1050~1052 (2020)
- Giannis D, "Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past", J Clin Virol, 127, pp.104362~ (2020)
- Han H, "Prominent changes in blood coagulation of patients with SARS-CoV-2 infection", Clin Chem Lab Med, 58, pp.1116~1120 (2020)
- Guan WJ, "Clinical characteristics of coronavirus disease 2019 in China", N Engl J Med, 382, pp.1708~1720 (2020)
- Huang C, "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", Lancet, 395, pp.497~506 (2020)
- Bivona Giulia, "Biomarkers for Prognosis and Treatment Response in COVID-19 Patients", Annals of Laboratory Medicine, 41(6), pp.540~548 (2021), 대한진단검사의학회[DOI]
- Zhang C, "Liver injury in COVID-19 : management and challenges", Lancet Gastroenterol Hepatol, 5, pp.428~430 (2020)
- Wu Y, "Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis", Hepatol Int, 14, pp.621~637 (2020)
- Herrmann FR, "Serum albumin level on admission as a predictor of death, length of stay, and readmission", Arch Intern Med, 152, pp.125~130 (1992)
- Lyons O, "Serum albumin as an outcome predictor in hospital emergency medical admissions", Eur J Intern Med, 21, pp.17~20 (2010)
- Li N, "Preoperative hypoalbuminemia was associated with acute kidney injury in high-risk patients following non-cardiac surgery : a retrospective cohort study", BMC Anesthesiol, 19, pp.171~ (2019)
- Ablett AD, "A practical risk scale for predicting morbidity and mortality in the emergency general surgical setting : A prospective multi-center study", Int J Surg, 60, pp.236~244 (2018)
- Young Ho Lee, "An overview of meta-analysis for clinicians", The Korean Journal of Internal Medicine, 33(2), pp.277~283 (2018), 대한내과학회[DOI]
- 장미애, "Effect of Accreditation on Accuracy of Diagnostic Tests in Medical Laboratories", Annals of Laboratory Medicine, 37(3), pp.213~222 (2017), 대한진단검사의학회